BioRestorative Therapies (BRTX) Earnings Analysis
BioRestorative Therapies (BRTX) next reports earnings on 2026-08-11, consensus EPS -0.15 USD. Last quarter (2026-05-14) it beat with EPS -0.19 USD vs -0.3 USD est (+36.7%). It has beaten estimates in 2/2 recent quarters (100%). Trailing P/E -0.26.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does BRTX next report earnings?
| Next earnings date | 2026-08-11 |
|---|---|
| Consensus EPS estimate | -0.15 USD |
| Revenue estimate | 0.00B |
BRTX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-14 | -0.19 USD | -0.3 USD | +36.7% | Beat |
| 2026-03-26 | -0.37 USD | -0.37 USD | 0% | Beat |
Beat rate: 2/2 (100%) over reported quarters with consensus data.
BRTX valuation and analyst view
| Trailing P/E | -0.26 |
|---|---|
| Trailing EPS | -1.22945 USD |
| Price / book | 0.94 |
| Dividend yield | 0.00% |
| Market cap | 0.00B |
| Analyst consensus | Buy (3 buy / 0 hold / 0 sell) |
Related research pages
Frequently asked questions
When is BioRestorative Therapies (BRTX)'s next earnings date?
BioRestorative Therapies is next scheduled to report on 2026-08-11, with a consensus EPS estimate of -0.15 USD and revenue estimate of 0.00B.
Did BRTX beat earnings last quarter?
In its 2026-05-14 report, BRTX posted EPS of -0.19 USD versus a -0.3 USD estimate — a beat of 36.7%.
What is BRTX's earnings track record?
Over the last 2 reported quarters with consensus data, BRTX beat estimates 2 times (100%).
What is BRTX's current P/E ratio and EPS?
BRTX trades at a trailing P/E of -0.26 on trailing EPS of -1.2294495288896006 USD.
What do analysts rate BRTX?
Analyst consensus is "Buy" across 3 ratings (0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell).